Search
Procept Biorobotics Corp
PRCTAdd to Watchlist
21.720USD
+0.810+3.87%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.22BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Procept Biorobotics Corp is 7.33, ranking 140 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 51.00, with a high of 75.00 and a low of 38.00.
Analyst Rating
Based on
15
analysts
Buy
Current Rating
32.750
Target Price
+50.78%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Procept Biorobotics Corp
PRCT
15
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Procept Biorobotics Corp's expected revenue for the next quarter?
Procept Biorobotics Corp's expected revenue is 93.06M.
What is Procept Biorobotics Corp's price target?
Analysts forecast that Procept Biorobotics Corp's price target is USD 51.00, with the highest forecast at USD 75.00 and the lowest forecast at USD 38.00.
How have Procept Biorobotics CorpPRCT's recent earnings per share performed?
The market expectation was USD -0.56, while Procept Biorobotics CorpPRCT's earnings per share (EPS) for the previous quarter was USD -0.53. EPS for the next quarter is expected at USD -0.46.
What is the analyst rating for Procept Biorobotics Corp?
Based on the ratings of Procept Biorobotics Corp's stock from 15 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
